The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2015 report summarizes the data from Maine’s PDMP. Continue reading
Resource Tag: Data
Monitoring and Changing Behavior: The Role of PMP Data in Kentucky Drug Courts
A 2011 report about how Kentucky’s drug courts access and use data from the state’s prescription drug monitoring program (PDMP) from the PDMP Center of Excellence at Brandeis University.
Continue reading
PBSS Data Brief: Patient Risk Measures for Controlled Substance Prescriptions in Idaho, 2012-2014
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report summarizes the data from Idaho’s PDMP. Continue reading
PBSS Issue Brief: Geographic Patterns in Neonatal Abstinence Syndrome and Prescription Opioids in Kentucky
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify treads in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report looks at the Continue reading
Opioid Poisoning Related Reporting
The 2018 Arizona regulations that codify the requirements that law enforcement, emergency medical responders, health care providers and health care facilities must report incidences of opioid overdoses, deaths due to opioid overdoses, and the number of naloxone doses dispensed and administered. Continue reading
Arizona Enhanced Opioid Data Surveillance
Arizona’s Department of Health Services adopted an enhanced opioid data surveillance program that requires first responders and health care providers to report suspected opioid overdoses, suspected opioid overdose deaths, naloxone distribution, and naloxone administration through an electronic reporting system. Providers are also required to report suspected cases of neonatal opioid withdrawal syndrome (neonatal abstinence syndrome). In addition, the state provides blood testing from suspected opioid overdoses by the public health laboratory and has a real time opioid data online dashboard. Links the project website, copies of the executive order and regulations, frequently asked questions, and implementation guides are available below.
Arizona’s 50 State Review on Opioid Policy
The Arizona Department of Health Services prepared this 2017 review of opioid related policies in all 50 states to assist decision-makers in evaluating potential policy actions. The review includes appendices which address topics such as prescribing regulations and guidelines, data collection, state substance abuse task forces, and state emergency response declarations. The reports are available for download below.
How to Report a Suspected Opioid/Opiate Overdose Using the AZ-PIERS System
Funding Source: Arizona Department of Health Services
Opioid Epidemic – Opioid Interactive Dashboard
This is the website for the Arizona enhanced opioid surveillance data project. It provides real time data on a variety of opioid topics including overdose, use of naloxone, neonatal withdrawal syndrome (or neonatal abstinence syndrome), and reports based on age, gender, and geographic location. Continue reading
Opioid Epidemic – Laboratory Screening
The Arizona State Public Health Laboratory has created a program to screen blood samples from individuals with a suspected opioid overdose in order to better understand which opioids are responsible for causing overdoses in the state. Health care providers and institutions can request a courier to pick up samples which are then tested for the qualitative identification of opioids, fentanyl analogs, benzodiazepines, stimulants, cannabinoids, and synthetic cannabinoids. This is the Arizona Department of Health Services website for the laboratory testing program. Continue reading